These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6714294)

  • 41. Antihypertensive effects of a new transdermal delivery system for clonidine (M-5041T) in spontaneously hypertensive rats.
    Ishii R; Naruse T; Tagawa T; Yamahata T; Dote S; Hamada K; Ishida T; Funabiki K; Namba K
    Arch Int Pharmacodyn Ther; 1994; 327(3):294-308. PubMed ID: 7848013
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clonidine twice daily in hypertension. Effects of two dosage regimens on blood pressure, side-effects and plasma clonidine concentrations.
    Lilja M; Huikuri H; Jounela AJ; Juustila HJ; Paalzow G
    Acta Med Scand; 1983; 214(2):111-7. PubMed ID: 6353878
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transdermal clonidine in the treatment of adolescent hypertension.
    Falkner B; Thanki B; Lowenthal DT
    J Hypertens Suppl; 1985 Dec; 3(4):S61-3. PubMed ID: 3868713
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The efficacy of a transdermal formulation of clonidine in mild to moderate hypertension and its effects on the arterial and venous vasculature of the forearm.
    Achimastos A; Girerd X; Simon AC; Pithois-Merli I; Levenson J
    Eur J Clin Pharmacol; 1987; 33(2):111-4. PubMed ID: 3691604
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics and pharmacodynamics of a new transdermal clonidine, M-5041T, in healthy subjects.
    Fujimura A; Ebihara A; Shiga T; Kumagai Y; Ohashi K; Nakashima H; Kotegawa T
    J Clin Pharmacol; 1993 Dec; 33(12):1192-200. PubMed ID: 8126254
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Pharmacokinetics of clonidine and chlorthalidone following subacute administration of a fixed combination compared with a sustained release formulation of clonidine alone (author's transl)].
    Arndts D; Doevendans J; Arendt G; Rippen G
    Arzneimittelforschung; 1981; 31(11):1954-7. PubMed ID: 7198476
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bioavailability and clinical effects of three brands of clonidine: the relationship between plasma level and effect.
    Kanto J; Allonen H; Hiltunen R; Marvola M; Mäntylä R
    Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):118-21. PubMed ID: 7068284
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical pharmacology and pharmacokinetics of clonidine.
    Dollery CT; Davies DS; Draffan GH; Dargie HJ; Dean CR; Reid JL; Clare RA; Murray S
    Clin Pharmacol Ther; 1976 Jan; 19(1):11-7. PubMed ID: 1245090
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative pharmacokinetics of oral versus sublingual clonidine.
    Cunningham FE; Baughman VL; Peters J; Laurito CE
    J Clin Anesth; 1994; 6(5):430-3. PubMed ID: 7986518
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiovascular withdrawal effects of clonidine and tiamenidine on abrupt cessation of oral treatment in conscious cats.
    Finch L; Hicks PE
    J Pharm Pharmacol; 1980 Apr; 32(4):272-7. PubMed ID: 6103057
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of clonidine in elderly patients with delirium; pharmacokinetics and hemodynamic responses.
    Hov KR; Neerland BE; Andersen AM; Undseth Ø; Wyller VB; MacLullich AMJ; Skovlund E; Qvigstad E; Wyller TB
    BMC Pharmacol Toxicol; 2018 Jun; 19(1):29. PubMed ID: 29884231
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of a slow-release clonidine preparation by direct continuous blood pressure recording in essential hypertensive patients.
    Mancia G; Ferrari A; Gregorini L; Parati G; Pomidossi G; Grassi G; Bertinieri G; Zanchetti A
    J Cardiovasc Pharmacol; 1981; 3(6):1193-202. PubMed ID: 6173518
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of chronic clonidine administration on sympathetic nerve traffic and baroreflex function in heart failure.
    Grassi G; Turri C; Seravalle G; Bertinieri G; Pierini A; Mancia G
    Hypertension; 2001 Aug; 38(2):286-91. PubMed ID: 11509491
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transdermal administration of clonidine for treatment of high BP.
    Weber MA; Drayer JI; McMahon FG; Hamburger R; Shah AR; Kirk LN
    Arch Intern Med; 1984 Jun; 144(6):1211-3. PubMed ID: 6375613
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term (5 year) experience with transdermal clonidine in the treatment of mild to moderate hypertension.
    Breidthardt J; Schumacher H; Mehlburger L
    Clin Auton Res; 1993 Dec; 3(6):385-90. PubMed ID: 8193526
    [TBL] [Abstract][Full Text] [Related]  

  • 56. One year efficacy and tolerability of clonidine administered by the transdermal route in patients with mild to moderate essential hypertension--a multicentre open label study. The Antihypertensive Patch Italian Study (APIS) Investigators.
    Clin Auton Res; 1993 Dec; 3(6):379-83. PubMed ID: 8193525
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
    Ishii R; Tagawa T; Ishida T; Naruse T
    Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Changes in plasma and urinary norepinephrine following transdermal clonidine in spontaneously hypertensive rats.
    Ishii R; Furuta M; Hashimoto M; Tagawa T; Naruse T; Hata T
    Arzneimittelforschung; 1998 Aug; 48(8):811-7. PubMed ID: 9748708
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Suppressive effects of transdermal clonidine administration on contact hypersensitivity reactions in guinea pigs.
    Goeptar AR; de Groot J; Lang M; van Tol RG; Scheper RJ
    Int J Immunopharmacol; 1988; 10(3):277-82. PubMed ID: 3182151
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetic and concentration-effect relationships of clonidine in essential hypertension.
    Wing LM; Reid JL; Davies DS; Neill EA; Tippett P; Dollery CT
    Eur J Clin Pharmacol; 1977 Dec; 12(6):463-9. PubMed ID: 598422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.